IN2014CN00436A - - Google Patents
Info
- Publication number
- IN2014CN00436A IN2014CN00436A IN436CHN2014A IN2014CN00436A IN 2014CN00436 A IN2014CN00436 A IN 2014CN00436A IN 436CHN2014 A IN436CHN2014 A IN 436CHN2014A IN 2014CN00436 A IN2014CN00436 A IN 2014CN00436A
- Authority
- IN
- India
- Prior art keywords
- protein
- prepared
- glu
- preparing
- lauroyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011139837 | 2011-06-23 | ||
PCT/JP2012/066121 WO2012176919A1 (ja) | 2011-06-23 | 2012-06-25 | 免疫グロブリン折りたたみ構造を持つタンパク質と、サブユニット構造となりうるタンパク質とを融合させた単量体タンパク質からなる多量体タンパク質の調製方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN00436A true IN2014CN00436A (ko) | 2015-04-03 |
Family
ID=47422745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN436CHN2014 IN2014CN00436A (ko) | 2011-06-23 | 2012-06-25 |
Country Status (7)
Country | Link |
---|---|
US (1) | US10308969B2 (ko) |
EP (1) | EP2725104B1 (ko) |
JP (1) | JP5858251B2 (ko) |
CN (2) | CN107365388B (ko) |
IL (1) | IL229682B (ko) |
IN (1) | IN2014CN00436A (ko) |
WO (1) | WO2012176919A1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2014CN00436A (ko) | 2011-06-23 | 2015-04-03 | Ajinomoto Kk |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2197210T3 (es) | 1994-11-30 | 2004-01-01 | Ajinomoto Co., Inc. | Agente antitrombotico y anticuerpos monoclonales contra el factor von willebrand. |
US7144991B2 (en) * | 1999-06-07 | 2006-12-05 | Aletheon Pharmaceuticals, Inc. | Streptavidin expressed gene fusions and methods of use thereof |
BRPI0407911A (pt) | 2003-03-07 | 2006-02-14 | Ajinomoto Kk | método para produzir uma transglutaminase ativa microbiana a partir de uma pró-transglutaminase microbiana, metaloprotease neutra de actionomicetos, molécula de ácido nucleico, e, método para produzir uma metaloprotease neutra de actinomicetos |
US8084032B2 (en) | 2004-01-21 | 2011-12-27 | Ajinomoto Co., Inc. | Purification method which prevents denaturation of an antibody |
WO2005103278A1 (ja) | 2004-04-20 | 2005-11-03 | Ajinomoto Co., Inc. | タンパク質の製造法 |
US8669045B2 (en) | 2007-02-13 | 2014-03-11 | Ajinomoto Co., Inc. | Method for inactivating viruses with slightly acidic arginine |
KR101162049B1 (ko) | 2007-02-15 | 2012-07-04 | 아지노모토 가부시키가이샤 | 디설파이드 결합 도입 트랜스글루타미나제 |
JP5168604B2 (ja) * | 2008-05-08 | 2013-03-21 | 味の素株式会社 | タンパク質のリフォールディング方法 |
WO2010101256A1 (ja) | 2009-03-06 | 2010-09-10 | 味の素株式会社 | 放線菌由来の耐熱性トランスグルタミナーゼ |
ES2544284T3 (es) | 2010-02-26 | 2015-08-28 | Ajinomoto Co., Inc. | Composición que inactiva virus que contiene un compuesto de bajo peso molecular y arginina |
IN2014CN00436A (ko) | 2011-06-23 | 2015-04-03 | Ajinomoto Kk |
-
2012
- 2012-06-25 IN IN436CHN2014 patent/IN2014CN00436A/en unknown
- 2012-06-25 WO PCT/JP2012/066121 patent/WO2012176919A1/ja unknown
- 2012-06-25 JP JP2013521655A patent/JP5858251B2/ja active Active
- 2012-06-25 CN CN201710550242.1A patent/CN107365388B/zh active Active
- 2012-06-25 CN CN201280030917.5A patent/CN103608463A/zh active Pending
- 2012-06-25 EP EP12803011.1A patent/EP2725104B1/en active Active
-
2013
- 2013-11-28 IL IL229682A patent/IL229682B/en active IP Right Grant
- 2013-12-12 US US14/104,139 patent/US10308969B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JPWO2012176919A1 (ja) | 2015-02-23 |
CN103608463A (zh) | 2014-02-26 |
CN107365388B (zh) | 2021-05-14 |
IL229682B (en) | 2018-04-30 |
EP2725104B1 (en) | 2019-08-21 |
JP5858251B2 (ja) | 2016-02-10 |
EP2725104A4 (en) | 2014-11-12 |
US10308969B2 (en) | 2019-06-04 |
WO2012176919A1 (ja) | 2012-12-27 |
IL229682A0 (en) | 2014-01-30 |
US20140099672A1 (en) | 2014-04-10 |
EP2725104A1 (en) | 2014-04-30 |
CN107365388A (zh) | 2017-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20237513B (en) | Improved methods for enhancing antibody productivity in mammalian cell culture and minimizing aggregation during downstream, formulation processes and stable antibody formulations obtained thereof | |
SG195306A1 (en) | Purification of biological products by constrained cohydration chromatography | |
BR112013026883A2 (pt) | Composição farmacêutica, kit compreendendo uma composição e método de produção de uma composição farmacêutica | |
CL2016000333A1 (es) | Proteínas de unión a il-1 | |
AR091098A1 (es) | ANTICUERPOS E INMUNOCONJUGADOS CONTRA Ly6E Y METODOS DE USO | |
EA201490815A1 (ru) | Составы этанерцепта, стабилизированные с помощью аминокислот | |
EA201991976A1 (ru) | Метаболически оптимизированная клеточная культура | |
BR112013023006A2 (pt) | formulações de suspensões não aquosas de anticorpos de alta concentração e viscosidade reduzida | |
BR112015013525A2 (pt) | método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão | |
ZA201403785B (en) | Compositions and methods for modifying a predetermined target nucleic acid sequence | |
NZ630848A (en) | Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide | |
EP2928924A4 (en) | HIV-1 ENV BINDING ANTIBODIES, FUSION PROTEINS AND METHODS OF USE | |
AR088322A1 (es) | Anticuerpos anti-htra1 y metodos de uso | |
WO2012054929A3 (en) | Use of human serum albumin to decrease antigenicity of therapeutic proteins | |
EA201400993A1 (ru) | Антитела против рецептора эпидермального фактора роста, активные в определенных условиях, и способы их применения | |
EA201400709A1 (ru) | Молекула биспецифического антитела | |
UA114902C2 (uk) | Виділене антитіло, яке зв'язує парний спіральний філамент-тау (псф-тау), та фармацевтична композиція, що містить таке антитіло | |
BR112015004467A2 (pt) | método para controlar a heterogeneidade de proteínas | |
NZ629204A (en) | Anti-vla1 (cd49a) antibody pharmaceutical compositions | |
MY181513A (en) | Cell culture compositions and methods for polypeptide production | |
MX356454B (es) | Una formulacion enzimatica liquida y un proceso para su preparacion. | |
NZ713602A (en) | Method for refining protein including self-cutting cassette and use thereof | |
EP2492689B8 (en) | Detection of antibodies using an improved immune complex (IC) ELISA | |
MX2014015088A (es) | Anticuerpos anti-tofacitinib y usos de los mismos para monitorear farmacos. | |
IN2014DN06660A (ko) |